- Home
- Publications
- Publication Search
- Publication Details
Title
Neurogranin as a Novel Biomarker in Alzheimer’s Disease
Authors
Keywords
-
Journal
Labmedicine
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-07-09
DOI
10.1093/labmed/lmaa062
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF α-synuclein correlates with CSF neurogranin in late-life depression
- (2020) Davide Bruno et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- An investigation of affective theory of mind ability and its relation to neuropsychological functions in Alzheimer's disease
- (2020) Elif Yildirim et al. Journal of Neuropsychology
- Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
- (2020) Henrik Zetterberg et al. MOLECULAR PSYCHIATRY
- Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis
- (2020) Luisa Agnello et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders
- (2019) Aylin Yilmaz et al. Current HIV/AIDS Reports
- CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD
- (2019) Kaj Blennow et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Vitamin D and the nervous system
- (2019) Giulia Bivona et al. NEUROLOGICAL RESEARCH
- Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence
- (2019) Imane Lejri et al. Oxidative Medicine and Cellular Longevity
- Biomarker profiles of Alzheimer’s disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau
- (2019) Aysha S. Mohamed Lafirdeen et al. PLoS One
- Non-Skeletal Activities of Vitamin D: From Physiology to Brain Pathology
- (2019) Giulia Bivona et al. Medicina-Lithuania
- α-synuclein in the pathophysiology of Alzheimer’s disease
- (2019) Daniel Twohig et al. Molecular Neurodegeneration
- Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
- (2019) Isabelle Bos et al. Alzheimers & Dementia
- Targeting the Synapse in Alzheimer’s Disease
- (2019) Johanna Jackson et al. Frontiers in Neuroscience
- Standardized measurement of circulating vitamin D [25(OH)D] and its putative role as a serum biomarker in Alzheimer's disease and Parkinson's disease
- (2019) Giulia Bivona et al. CLINICA CHIMICA ACTA
- Italian consensus recommendations for a biomarker‐based aetiological diagnosis in mild cognitive impairment patients
- (2019) M. Boccardi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- The Past and the Future of Alzheimer’s Disease Fluid Biomarkers
- (2018) Kaj Blennow et al. JOURNAL OF ALZHEIMERS DISEASE
- The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
- (2018) Daniel Twohig et al. Acta Neuropathologica Communications
- Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2017) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects
- (2017) Siranjeevi Nagaraj et al. Oncotarget
- Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)
- (2017) Hugo Vanderstichele et al. Alzheimers Research & Therapy
- Impaired synaptic function is linked to cognition in Parkinson's disease
- (2017) Per Selnes et al. Annals of Clinical and Translational Neurology
- CSF α-Synuclein Does Not Discriminate Dementia with Lewy Bodies from Alzheimer's Disease
- (2017) Fransje E. Reesink et al. JOURNAL OF ALZHEIMERS DISEASE
- Defining the earliest pathological changes of Alzheimer's disease
- (2016) James C. Vickers et al. Current Alzheimer Research
- Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
- (2016) Niklas Mattsson et al. EMBO Molecular Medicine
- Increased CSF neurogranin concentration is specific to Alzheimer disease
- (2016) Henrietta Wellington et al. NEUROLOGY
- CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
- (2016) Julia Remnestål et al. Proteomics Clinical Applications
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
- (2015) Hlin Kvartsberg et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease
- (2015) Erik Portelius et al. BRAIN
- Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease
- (2015) Edward J. Goetzl et al. NEUROLOGY
- Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
- (2015) Konstantin Hellwig et al. Alzheimers Research & Therapy
- Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
- (2015) Maartje I. Kester et al. JAMA Neurology
- The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2014) José Luis Molinuevo et al. Alzheimers & Dementia
- Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease
- (2014) Mitsuru Shinohara et al. BRAIN
- Tau phosphorylation affects its axonal transport and degradation
- (2013) Teresa Rodríguez-Martín et al. NEUROBIOLOGY OF AGING
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- Soluble -Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology
- (2012) M. E. Larson et al. JOURNAL OF NEUROSCIENCE
- Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
- (2011) Fuyuki Tateno et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Neurogranin, a link between calcium/calmodulin and protein kinase C signaling in synaptic plasticity
- (2010) F. Javier Díez-Guerra IUBMB LIFE
- The role of alpha-synuclein in neurotransmission and synaptic plasticity
- (2010) Furong Cheng et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Neuropathology of Alzheimer's Disease
- (2010) Daniel P. Perl MOUNT SINAI JOURNAL OF MEDICINE
- Disease progression meta-analysis model in Alzheimer's disease
- (2009) Kaori Ito et al. Alzheimers & Dementia
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Alzheimer's disease: synaptic dysfunction and Aβ
- (2009) Ganesh M Shankar et al. Molecular Neurodegeneration
- Elevated Cerebrospinal Fluid Tau Protein Levels in Wernicke’s Encephalopathy
- (2008) Sachio Matsushita et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin
- (2008) Inmaculada Cuchillo-Ibanez et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now